Smart Pills Market By Application (Diagnostic Imaging, Vital Sign Monitoring, Targeted Drug Delivery); By Area (Esophagus, Stomach, Small Intestine, Large Intestine, Others); By Disease Indication (Acute gastrointestinal bleeding, Crohn’s disease (CD), Esophagitis and Barrett’s esophagus, Others); By End User (Hospitals, Clinics, Diagnostic Centers, Research Centers, Universities, Others); By Region (U.S., Canada, Mexico, Rest of North America, The UK, France, Germany, Italy, Spain, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, the Netherlands, Luxembourg), Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2020-2028
Industry Trends
The advancement in medical technology plays a crucial role in determining the life expectancy of individuals. Diagnosis and treatment methods in healthcare have seen significant development in recent years, predominantly due to the innovation in manufacturing technology, coupled with government initiatives to promote quality healthcare in both developing and developed countries around the globe. One such advancement is that of the development of smart pills. Smart pills, also called as electronic pills or digital pills, are medications which are prescribed to patients and are incorporated with electronic sensors that helps in tracking medical compliance, and can be used for diagnosis of gastrointestinal diseases. Initially, the smart pill was approved for use in the U.S. Food and Drug Administration (FDA) in 2017 for the treatment of schizophrenia, bipolar and other depressive disorders. The electronic sensors present in the smart pills are capable of interacting with devices such as medical patches, tablets, smartphones and computers, etc., that helps in evaluating numerous parameters in an individual's body. Researchers believe that the advent of smart pills will allow the healthcare professionals to keep track of a patient's drug regiment compliance, thereby increasing the effectiveness of the drugs. Studies show that the use of smart pills will result in savings of around US$ 100 billion to US$ 300 billion in the U.S. alone, primarily due to the reduction in drug intake. The rising demand for advanced diagnostics methods which are not invasive, coupled with targeted drug delivery features offered by smart pills is leading to the growth of the global smart pills market.
The COVID-19 pandemic has drastically impacted the lives of individuals across the globe. Country-wide lockdown has been imposed in several countries. In the UK, for instance, the government is enforcing complete lockdown to prevent the spread of the mutated strain of COVID-19. Vaccine manufacturers are increasingly seeking to optimize the efficiency of the COVID-19 vaccine. Smart pills have the potential of delivering the drugs at the intended location, thereby helping in increasing the efficiency of treatment. Furthermore, smart pills can be used on individuals who have been affected by the Coronavirus to study the reaction of the virus on the human body. Stomach-related illnesses can be easily analysed with the use of smart pills. Therefore, the pandemic is expected to have a positive impact on the global smart pills market, and the market seems to be an attractive investment option in the coming years.
In terms of revenue, the global smart pills market was valued at US$ 3234.14 Mn in 2019 and is anticipated to grow at a CAGR of 18.50% over the forecast period. The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Smart Pills Market Revenue & Forecast, (US$ Million), 2015 – 2028
Application Outlook:
The major applications of smart pills include diagnostic imaging, vital sign monitoring, and targeted drug delivery. Diagnostic imaging accounted for a considerable share in the global smart pills market in 2019. The world of diagnostic imaging for the diagnosis of gastrointestinal diseases is being revolutionised after the arrival of smart pills. They are expected to replace traditional endoscopic and colonoscopy procedures in the near future. A smart pill can be swallowed easily, and accurate imaging of the organs can be obtained on a connected device. Ease in manoeuvring is also provided by smart pills, and the patient needn't be prepared in advance using sedative techniques for the use of smart pills. Furthermore, the single-time use feature of smart pills ensures that the risk of patient contamination is completely eliminated. This is immensely beneficial in underdeveloped countries. The sensors present in the smart pills allow healthcare professionals to study the nature of fluids and gases present in the gut, thereby helping in providing a multivariate analysis of the gastrointestinal region. Faster diagnosis can be obtained using these factors. Medtronic, for instance, provides a smart pill named as PillCam COLON, which provides an accurate visualization of the colon for the diagnosis of colon cancer. The device is also free of any radiation, thereby eliminating the risk of radiation contamination. These factors resulted in diagnostic imaging accounting for a significant share of the revenue in the global smart pills market.
Region Outlook:
North America accounted for the highest share in the global smart pills market as far as the geography is concerned. This is primarily because the healthcare providers in North America, especially in the U.S., are making use of smart pills for the diagnosis of gastrointestinal illnesses. In the U.S. alone, figures from the U.S. Centers for Disease Control and Prevention show that around 60 million to 70 million individuals fall prey to gastrointestinal diseases annually. Endoscopy procedures, which are generally invasive in nature, cause discomfort in patients, especially in children and the elderly. Furthermore, colon cancer is on the rise in the U.S. In 2020, around 148,000 adults in the U.S. were expected to be diagnosed with colorectal cancer. Amongst these, around 104,000 new cases of colon cancer were also expected. Colonoscopy procedures which help in the diagnosis or screening of colorectal cancer amount for millions of dollars in healthcare expenditure. These procedures have a high risk of causing internal bleeding in patients, and may also increase the risk of infection due to reuse. Therefore, healthcare professionals are increasingly using smart pills which dissolve after the use for the diagnosis of cancer and other illnesses. Moreover, the region also has the presence of numerous smart pills providers such as HQ, Inc, BDD Pharma, Capsovision, Inc., Medtronic, etc., which makes it easier for the healthcare professionals to access these pills. However, the APAC region is expected to show the highest growth during the forecast years in the global smart pills market. The rising focus on the development of smart pills in countries such as India, China, Japan, etc., and the growth in awareness amongst the healthcare facilities in the APAC region regarding the use of smart pills is expected to drive the growth of the APAC region in the global smart pills market. In China, for instance, Jinshan Science & Technology (Group) provides a OMOM HD Capsule Endoscopy Platform that combines Artificial Intelligence and advanced optical imaging to help in the study of abnormalities in the gastrointestinal region. It is equipped with a battery that provides 12 hours of working time, and also has a lens which enables a viewing angle of 172 degrees. Also, the government bodies in China, India, Japan, South Korea and Singapore are increasingly focussing on decreasing the gastrointestinal disease burden with faster diagnosis and effective treatment of individuals. There is a growing demand for video endoscopy through the use of smart capsules in these countries, which is expected to further the share of the APAC region in the coming years.
Competitive Landscape
The report provides both, qualitative and quantitative research of smart pills market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the smart pills market are BDD Pharma Ltd, CapsoVision, Inc, Check-Cap, etectRx, HQ, Inc., Jinshan Science & Technology (Group) Co., Ltd., Medimetrics Personalized Drug Delivery B.V., Medtronic, Olympus, Veloce Digital Health, amongst others
Global Smart Pills Market:
- By Application
- Diagnostic Imaging
- Vital Sign Monitoring
- Targeted Drug Delivery
- By Area
- Esophagus
- Stomach
- Small Intestine
- Large Intestine
- Others
- By Disease Indication
- Acute gastrointestinal bleeding
- Crohn’s disease (CD)
- Esophagitis and Barrett’s esophagus
- Others
- By Region:
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- North America
Table of Contents
1. Market
Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2018
1.2.2. Base
Year: 2019
1.2.3. Forecast
Years: 2020 – 2028
2. Key Target
Audiences
3. Research
Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations
and Insights from AMI’s Perspective**
5. Holistic
Overview of Smart Pills Market
6. Market
Synopsis: Smart Pills Market
7. Smart Pills
Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in Smart
Pills Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Smart Pills Market
7.6. Porter’s Five Force Analysis
7.7. Impact of
Covid-19 on Smart Pills Market
8. Global
Smart Pills Market Analysis and Forecasts, 2020 – 2028
8.1. Overview
8.1.1. Global
Smart Pills Market Revenue (US$ Mn)
8.2. Global
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Application
8.2.1. Diagnostic
Imaging
8.2.1.1. Definition
8.2.1.2. Market
Estimation and Penetration, 2015 – 2019
8.2.1.3. Market
Forecast, 2020 – 2028
8.2.1.4. Compound
Annual Growth Rate (CAGR)
8.2.1.5. Regional
Bifurcation
8.2.1.5.1. North
America
8.2.1.5.1.1. Market
Estimation, 2015 – 2019
8.2.1.5.1.2. Market
Forecast, 2020 – 2028
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2015 – 2019
8.2.1.5.2.2. Market
Forecast, 2020 – 2028
8.2.1.5.3. Asia
Pacific
8.2.1.5.3.1. Market
Estimation, 2015 – 2019
8.2.1.5.3.2. Market
Forecast, 2020 – 2028
8.2.1.5.4. Middle
East and Africa
8.2.1.5.4.1. Market
Estimation, 2015 – 2019
8.2.1.5.4.2. Market
Forecast, 2020 – 2028
8.2.1.5.5. Latin
America
8.2.1.5.5.1. Market
Estimation, 2015 – 2019
8.2.1.5.5.2. Market
Forecast, 2020 – 2028
8.2.2. Vital
Sign Monitoring
8.2.2.1. Definition
8.2.2.2. Market
Estimation and Penetration, 2015 – 2019
8.2.2.3. Market
Forecast, 2020 – 2028
8.2.2.4. Compound
Annual Growth Rate (CAGR)
8.2.2.5. Regional
Bifurcation
8.2.2.5.1. North
America
8.2.2.5.1.1. Market
Estimation, 2015 – 2019
8.2.2.5.1.2. Market
Forecast, 2020 – 2028
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 – 2019
8.2.2.5.2.2. Market
Forecast, 2020 – 2028
8.2.2.5.3. Asia
Pacific
8.2.2.5.3.1. Market
Estimation, 2015 – 2019
8.2.2.5.3.2. Market
Forecast, 2020 – 2028
8.2.2.5.4. Middle
East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 – 2019
8.2.2.5.4.2. Market
Forecast, 2020 – 2028
8.2.2.5.5. Latin
America
8.2.2.5.5.1. Market
Estimation, 2015 – 2019
8.2.2.5.5.2. Market
Forecast, 2020 – 2028
8.2.3. Targeted
Drug Delivery
8.2.3.1. Definition
8.2.3.2. Market
Estimation and Penetration, 2015 – 2019
8.2.3.3. Market
Forecast, 2020 – 2028
8.2.3.4. Compound
Annual Growth Rate (CAGR)
8.2.3.5. Regional
Bifurcation
8.2.3.5.1. North
America
8.2.3.5.1.1. Market
Estimation, 2015 – 2019
8.2.3.5.1.2. Market
Forecast, 2020 – 2028
8.2.3.5.2. Europe
8.2.3.5.2.1. Market
Estimation, 2015 – 2019
8.2.3.5.2.2. Market
Forecast, 2020 – 2028
8.2.3.5.3. Asia
Pacific
8.2.3.5.3.1. Market
Estimation, 2015 – 2019
8.2.3.5.3.2. Market
Forecast, 2020 – 2028
8.2.3.5.4. Middle
East and Africa
8.2.3.5.4.1. Market
Estimation, 2015 – 2019
8.2.3.5.4.2. Market
Forecast, 2020 – 2028
8.2.3.5.5. Latin
America
8.2.3.5.5.1. Market
Estimation, 2015 – 2019
8.2.3.5.5.2. Market
Forecast, 2020 – 2028
8.3. Key
Segment for Channeling Investments
8.3.1. By
Application
9. Global
Smart Pills Market Analysis and Forecasts, 2020 – 2028
9.1. Overview
9.2. Global
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Area
9.2.1. Esophagus
9.2.1.1. Definition
9.2.1.2. Market
Estimation and Penetration, 2015 – 2019
9.2.1.3. Market
Forecast, 2020 – 2028
9.2.1.4. Compound
Annual Growth Rate (CAGR)
9.2.1.5. Regional
Bifurcation
9.2.1.5.1. North
America
9.2.1.5.1.1. Market
Estimation, 2015 – 2019
9.2.1.5.1.2. Market
Forecast, 2020 – 2028
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 – 2019
9.2.1.5.2.2. Market
Forecast, 2020 – 2028
9.2.1.5.3. Asia
Pacific
9.2.1.5.3.1. Market
Estimation, 2015 – 2019
9.2.1.5.3.2. Market
Forecast, 2020 – 2028
9.2.1.5.4. Middle
East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 – 2019
9.2.1.5.4.2. Market
Forecast, 2020 – 2028
9.2.1.5.5. Latin
America
9.2.1.5.5.1. Market
Estimation, 2015 – 2019
9.2.1.5.5.2. Market
Forecast, 2020 – 2028
9.2.2. Stomach
9.2.2.1. Definition
9.2.2.2. Market
Estimation and Penetration, 2015 – 2019
9.2.2.3. Market
Forecast, 2020 – 2028
9.2.2.4. Compound
Annual Growth Rate (CAGR)
9.2.2.5. Regional
Bifurcation
9.2.2.5.1. North
America
9.2.2.5.1.1. Market
Estimation, 2015 – 2019
9.2.2.5.1.2. Market
Forecast, 2020 – 2028
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 – 2019
9.2.2.5.2.2. Market
Forecast, 2020 – 2028
9.2.2.5.3. Asia
Pacific
9.2.2.5.3.1. Market
Estimation, 2015 – 2019
9.2.2.5.3.2. Market
Forecast, 2020 – 2028
9.2.2.5.4. Middle
East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 – 2019
9.2.2.5.4.2. Market
Forecast, 2020 – 2028
9.2.2.5.5. Latin
America
9.2.2.5.5.1. Market
Estimation, 2015 – 2019
9.2.2.5.5.2. Market
Forecast, 2020 – 2028
9.2.3. Small
Intestine
9.2.3.1. Definition
9.2.3.2. Market
Estimation and Penetration, 2015 – 2019
9.2.3.3. Market
Forecast, 2020 – 2028
9.2.3.4. Compound
Annual Growth Rate (CAGR)
9.2.3.5. Regional
Bifurcation
9.2.3.5.1. North
America
9.2.3.5.1.1. Market
Estimation, 2015 – 2019
9.2.3.5.1.2. Market
Forecast, 2020 – 2028
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 – 2019
9.2.3.5.2.2. Market
Forecast, 2020 – 2028
9.2.3.5.3. Asia
Pacific
9.2.3.5.3.1. Market
Estimation, 2015 – 2019
9.2.3.5.3.2. Market
Forecast, 2020 – 2028
9.2.3.5.4. Middle
East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 – 2019
9.2.3.5.4.2. Market
Forecast, 2020 – 2028
9.2.3.5.5. Latin
America
9.2.3.5.5.1. Market
Estimation, 2015 – 2019
9.2.3.5.5.2. Market
Forecast, 2020 – 2028
9.2.4. Large
Intestine
9.2.4.1. Definition
9.2.4.2. Market
Estimation and Penetration, 2015 – 2019
9.2.4.3. Market
Forecast, 2020 – 2028
9.2.4.4. Compound
Annual Growth Rate (CAGR)
9.2.4.5. Regional
Bifurcation
9.2.4.5.1. North
America
9.2.4.5.1.1. Market
Estimation, 2015 – 2019
9.2.4.5.1.2. Market
Forecast, 2020 – 2028
9.2.4.5.2. Europe
9.2.4.5.2.1. Market
Estimation, 2015 – 2019
9.2.4.5.2.2. Market
Forecast, 2020 – 2028
9.2.4.5.3. Asia
Pacific
9.2.4.5.3.1. Market
Estimation, 2015 – 2019
9.2.4.5.3.2. Market
Forecast, 2020 – 2028
9.2.4.5.4. Middle
East and Africa
9.2.4.5.4.1. Market
Estimation, 2015 – 2019
9.2.4.5.4.2. Market
Forecast, 2020 – 2028
9.2.4.5.5. Latin
America
9.2.4.5.5.1. Market
Estimation, 2015 – 2019
9.2.4.5.5.2. Market
Forecast, 2020 – 2028
9.2.5. Others
9.2.5.1. Definition
9.2.5.2. Market
Estimation and Penetration, 2015 – 2019
9.2.5.3. Market
Forecast, 2020 – 2028
9.2.5.4. Compound
Annual Growth Rate (CAGR)
9.2.5.5. Regional
Bifurcation
9.2.5.5.1. North
America
9.2.5.5.1.1. Market
Estimation, 2015 – 2019
9.2.5.5.1.2. Market
Forecast, 2020 – 2028
9.2.5.5.2. Europe
9.2.5.5.2.1. Market
Estimation, 2015 – 2019
9.2.5.5.2.2. Market
Forecast, 2020 – 2028
9.2.5.5.3. Asia
Pacific
9.2.5.5.3.1. Market
Estimation, 2015 – 2019
9.2.5.5.3.2. Market
Forecast, 2020 – 2028
9.2.5.5.4. Middle
East and Africa
9.2.5.5.4.1. Market
Estimation, 2015 – 2019
9.2.5.5.4.2. Market
Forecast, 2020 – 2028
9.2.5.5.5. Latin
America
9.2.5.5.5.1. Market
Estimation, 2015 – 2019
9.2.5.5.5.2. Market
Forecast, 2020 – 2028
9.3. Key
Segment for Channeling Investments
9.3.1. By Area
10. Global
Smart Pills Market Analysis and Forecasts, 2020 – 2028
10.1. Overview
10.2. Global
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Disease Indication
10.2.1. Acute
Gastrointestinal Bleeding
10.2.1.1. Definition
10.2.1.2. Market
Estimation and Penetration, 2015 – 2019
10.2.1.3. Market
Forecast, 2020 – 2028
10.2.1.4. Compound
Annual Growth Rate (CAGR)
10.2.1.5. Regional
Bifurcation
10.2.1.5.1. North
America
10.2.1.5.1.1. Market
Estimation, 2015 – 2019
10.2.1.5.1.2. Market
Forecast, 2020 – 2028
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 – 2019
10.2.1.5.2.2. Market
Forecast, 2020 – 2028
10.2.1.5.3. Asia
Pacific
10.2.1.5.3.1. Market
Estimation, 2015 – 2019
10.2.1.5.3.2. Market
Forecast, 2020 – 2028
10.2.1.5.4. Middle
East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 – 2019
10.2.1.5.4.2. Market
Forecast, 2020 – 2028
10.2.1.5.5. Latin
America
10.2.1.5.5.1. Market
Estimation, 2015 – 2019
10.2.1.5.5.2. Market
Forecast, 2020 – 2028
10.2.2. Crohn’s
Disease (CD)
10.2.2.1. Definition
10.2.2.2. Market
Estimation and Penetration, 2015 – 2019
10.2.2.3. Market
Forecast, 2020 – 2028
10.2.2.4. Compound
Annual Growth Rate (CAGR)
10.2.2.5. Regional
Bifurcation
10.2.2.5.1. North
America
10.2.2.5.1.1. Market
Estimation, 2015 – 2019
10.2.2.5.1.2. Market
Forecast, 2020 – 2028
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 – 2019
10.2.2.5.2.2. Market
Forecast, 2020 – 2028
10.2.2.5.3. Asia
Pacific
10.2.2.5.3.1. Market
Estimation, 2015 – 2019
10.2.2.5.3.2. Market
Forecast, 2020 – 2028
10.2.2.5.4. Middle
East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 – 2019
10.2.2.5.4.2. Market
Forecast, 2020 – 2028
10.2.2.5.5. Latin
America
10.2.2.5.5.1. Market
Estimation, 2015 – 2019
10.2.2.5.5.2. Market
Forecast, 2020 – 2028
10.2.3. Esophagitis
and Barrett’s Esophagus
10.2.3.1. Definition
10.2.3.2. Market
Estimation and Penetration, 2015 – 2019
10.2.3.3. Market
Forecast, 2020 – 2028
10.2.3.4. Compound
Annual Growth Rate (CAGR)
10.2.3.5. Regional
Bifurcation
10.2.3.5.1. North
America
10.2.3.5.1.1. Market
Estimation, 2015 – 2019
10.2.3.5.1.2. Market
Forecast, 2020 – 2028
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation, 2015 – 2019
10.2.3.5.2.2. Market
Forecast, 2020 – 2028
10.2.3.5.3. Asia
Pacific
10.2.3.5.3.1. Market
Estimation, 2015 – 2019
10.2.3.5.3.2. Market
Forecast, 2020 – 2028
10.2.3.5.4. Middle
East and Africa
10.2.3.5.4.1. Market
Estimation, 2015 – 2019
10.2.3.5.4.2. Market
Forecast, 2020 – 2028
10.2.3.5.5. Latin
America
10.2.3.5.5.1. Market
Estimation, 2015 – 2019
10.2.3.5.5.2. Market
Forecast, 2020 – 2028
10.2.4. Others
10.2.4.1. Definition
10.2.4.2. Market
Estimation and Penetration, 2015 – 2019
10.2.4.3. Market
Forecast, 2020 – 2028
10.2.4.4. Compound
Annual Growth Rate (CAGR)
10.2.4.5. Regional
Bifurcation
10.2.4.5.1. North
America
10.2.4.5.1.1. Market
Estimation, 2015 – 2019
10.2.4.5.1.2. Market
Forecast, 2020 – 2028
10.2.4.5.2. Europe
10.2.4.5.2.1. Market
Estimation, 2015 – 2019
10.2.4.5.2.2. Market
Forecast, 2020 – 2028
10.2.4.5.3. Asia
Pacific
10.2.4.5.3.1. Market
Estimation, 2015 – 2019
10.2.4.5.3.2. Market
Forecast, 2020 – 2028
10.2.4.5.4. Middle
East and Africa
10.2.4.5.4.1. Market
Estimation, 2015 – 2019
10.2.4.5.4.2. Market
Forecast, 2020 – 2028
10.2.4.5.5. Latin
America
10.2.4.5.5.1. Market
Estimation, 2015 – 2019
10.2.4.5.5.2. Market
Forecast, 2020 – 2028
10.3. Key
Segment for Channeling Investments
10.3.1. By Disease
Indication
11. Global
Smart Pills Market Analysis and Forecasts, 2020 – 2028
11.1. Overview
11.2. Global
Smart Pills Market Revenue (US$ Mn) and Forecasts, By End Users
11.2.1. Hospitals
11.2.1.1. Definition
11.2.1.2. Market
Estimation and Penetration, 2015 – 2019
11.2.1.3. Market
Forecast, 2020 – 2028
11.2.1.4. Compound
Annual Growth Rate (CAGR)
11.2.1.5. Regional
Bifurcation
11.2.1.5.1. North
America
11.2.1.5.1.1. Market
Estimation, 2015 – 2019
11.2.1.5.1.2. Market
Forecast, 2020 – 2028
11.2.1.5.2. Europe
11.2.1.5.2.1. Market
Estimation, 2015 – 2019
11.2.1.5.2.2. Market
Forecast, 2020 – 2028
11.2.1.5.3. Asia
Pacific
11.2.1.5.3.1. Market
Estimation, 2015 – 2019
11.2.1.5.3.2. Market
Forecast, 2020 – 2028
11.2.1.5.4. Middle
East and Africa
11.2.1.5.4.1. Market
Estimation, 2015 – 2019
11.2.1.5.4.2. Market
Forecast, 2020 – 2028
11.2.1.5.5. Latin
America
11.2.1.5.5.1. Market
Estimation, 2015 – 2019
11.2.1.5.5.2. Market
Forecast, 2020 – 2028
11.2.2. Clinics
11.2.2.1. Definition
11.2.2.2. Market
Estimation and Penetration, 2015 – 2019
11.2.2.3. Market
Forecast, 2020 – 2028
11.2.2.4. Compound
Annual Growth Rate (CAGR)
11.2.2.5. Regional
Bifurcation
11.2.2.5.1. North
America
11.2.2.5.1.1. Market
Estimation, 2015 – 2019
11.2.2.5.1.2. Market
Forecast, 2020 – 2028
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation, 2015 – 2019
11.2.2.5.2.2. Market
Forecast, 2020 – 2028
11.2.2.5.3. Asia
Pacific
11.2.2.5.3.1. Market
Estimation, 2015 – 2019
11.2.2.5.3.2. Market
Forecast, 2020 – 2028
11.2.2.5.4. Middle
East and Africa
11.2.2.5.4.1. Market
Estimation, 2015 – 2019
11.2.2.5.4.2. Market
Forecast, 2020 – 2028
11.2.2.5.5. Latin
America
11.2.2.5.5.1. Market
Estimation, 2015 – 2019
11.2.2.5.5.2. Market
Forecast, 2020 – 2028
11.2.3. Diagnostic
Centers
11.2.3.1. Definition
11.2.3.2. Market
Estimation and Penetration, 2015 – 2019
11.2.3.3. Market
Forecast, 2020 – 2028
11.2.3.4. Compound
Annual Growth Rate (CAGR)
11.2.3.5. Regional
Bifurcation
11.2.3.5.1. North
America
11.2.3.5.1.1. Market
Estimation, 2015 – 2019
11.2.3.5.1.2. Market
Forecast, 2020 – 2028
11.2.3.5.2. Europe
11.2.3.5.2.1. Market
Estimation, 2015 – 2019
11.2.3.5.2.2. Market
Forecast, 2020 – 2028
11.2.3.5.3. Asia
Pacific
11.2.3.5.3.1. Market
Estimation, 2015 – 2019
11.2.3.5.3.2. Market
Forecast, 2020 – 2028
11.2.3.5.4. Middle
East and Africa
11.2.3.5.4.1. Market
Estimation, 2015 – 2019
11.2.3.5.4.2. Market
Forecast, 2020 – 2028
11.2.3.5.5. Latin
America
11.2.3.5.5.1. Market
Estimation, 2015 – 2019
11.2.3.5.5.2. Market
Forecast, 2020 – 2028
11.2.4. Research
Centers
11.2.4.1. Definition
11.2.4.2. Market
Estimation and Penetration, 2015 – 2019
11.2.4.3. Market
Forecast, 2020 – 2028
11.2.4.4. Compound
Annual Growth Rate (CAGR)
11.2.4.5. Regional
Bifurcation
11.2.4.5.1. North
America
11.2.4.5.1.1. Market
Estimation, 2015 – 2019
11.2.4.5.1.2. Market
Forecast, 2020 – 2028
11.2.4.5.2. Europe
11.2.4.5.2.1. Market
Estimation, 2015 – 2019
11.2.4.5.2.2. Market
Forecast, 2020 – 2028
11.2.4.5.3. Asia
Pacific
11.2.4.5.3.1. Market
Estimation, 2015 – 2019
11.2.4.5.3.2. Market
Forecast, 2020 – 2028
11.2.4.5.4. Middle
East and Africa
11.2.4.5.4.1. Market
Estimation, 2015 – 2019
11.2.4.5.4.2. Market
Forecast, 2020 – 2028
11.2.4.5.5. Latin
America
11.2.4.5.5.1. Market
Estimation, 2015 – 2019
11.2.4.5.5.2. Market
Forecast, 2020 – 2028
11.2.5. Universities
11.2.5.1. Definition
11.2.5.2. Market
Estimation and Penetration, 2015 – 2019
11.2.5.3. Market
Forecast, 2020 – 2028
11.2.5.4. Compound
Annual Growth Rate (CAGR)
11.2.5.5. Regional
Bifurcation
11.2.5.5.1. North
America
11.2.5.5.1.1. Market
Estimation, 2015 – 2019
11.2.5.5.1.2. Market
Forecast, 2020 – 2028
11.2.5.5.2. Europe
11.2.5.5.2.1. Market
Estimation, 2015 – 2019
11.2.5.5.2.2. Market
Forecast, 2020 – 2028
11.2.5.5.3. Asia
Pacific
11.2.5.5.3.1. Market
Estimation, 2015 – 2019
11.2.5.5.3.2. Market
Forecast, 2020 – 2028
11.2.5.5.4. Middle
East and Africa
11.2.5.5.4.1. Market
Estimation, 2015 – 2019
11.2.5.5.4.2. Market
Forecast, 2020 – 2028
11.2.5.5.5. Latin
America
11.2.5.5.5.1. Market
Estimation, 2015 – 2019
11.2.5.5.5.2. Market
Forecast, 2020 – 2028
11.2.6. Others
11.2.6.1. Definition
11.2.6.2. Market
Estimation and Penetration, 2015 – 2019
11.2.6.3. Market
Forecast, 2020 – 2028
11.2.6.4. Compound
Annual Growth Rate (CAGR)
11.2.6.5. Regional
Bifurcation
11.2.6.5.1. North
America
11.2.6.5.1.1. Market
Estimation, 2015 – 2019
11.2.6.5.1.2. Market
Forecast, 2020 – 2028
11.2.6.5.2. Europe
11.2.6.5.2.1. Market
Estimation, 2015 – 2019
11.2.6.5.2.2. Market
Forecast, 2020 – 2028
11.2.6.5.3. Asia
Pacific
11.2.6.5.3.1. Market
Estimation, 2015 – 2019
11.2.6.5.3.2. Market
Forecast, 2020 – 2028
11.2.6.5.4. Middle
East and Africa
11.2.6.5.4.1. Market
Estimation, 2015 – 2019
11.2.6.5.4.2. Market
Forecast, 2020 – 2028
11.2.6.5.5. Latin
America
11.2.6.5.5.1. Market
Estimation, 2015 – 2019
11.2.6.5.5.2. Market
Forecast, 2020 – 2028
11.3. Key
Segment for Channeling Investments
11.3.1. By End
Users
12. North
America Smart Pills Market Analysis and Forecasts, 2020 - 2028
12.1. Overview
12.1.1. North
America Smart Pills Market Revenue (US$ Mn)
12.2. North
America Smart Pills Market Revenue (US$ Mn) and Forecasts, By Application
12.2.1. Diagnostic
Imaging
12.2.2. Vital
Sign Monitoring
12.2.3. Targeted
Drug Delivery
12.3. North
America Smart Pills Market Revenue (US$ Mn) and Forecasts, By Area
12.3.1. Esophagus
12.3.2. Stomach
12.3.3. Small
Intestine
12.3.4. Large
Intestine
12.3.5. Others
12.4. North
America Smart Pills Market Revenue (US$ Mn) and Forecasts, By Disease
Indication
12.4.1. Acute
Gastrointestinal Bleeding
12.4.2. Crohn’s
Disease (CD)
12.4.3. Esophagitis
and Barrett’s Esophagus
12.4.4. Others
12.5. North
America Smart Pills Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.1. Hospitals
12.5.2. Clinics
12.5.3. Diagnostic
Centers
12.5.4. Research
Centers
12.5.5. Universities
12.5.6. Others
12.6. North
America Smart Pills Market Revenue (US$ Mn) and Forecasts, By Country
12.6.1. U.S
12.6.1.1. U.S
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Application
12.6.1.1.1. Diagnostic
Imaging
12.6.1.1.2. Vital
Sign Monitoring
12.6.1.1.3. Targeted
Drug Delivery
12.6.1.2. U.S
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Area
12.6.1.2.1. Esophagus
12.6.1.2.2. Stomach
12.6.1.2.3. Small
Intestine
12.6.1.2.4. Large
Intestine
12.6.1.2.5. Others
12.6.1.3. U.S
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Disease Indication
12.6.1.3.1. Acute
Gastrointestinal Bleeding
12.6.1.3.2. Crohn’s
Disease (CD)
12.6.1.3.3. Esophagitis
and Barrett’s Esophagus
12.6.1.3.4. Others
12.6.1.4. U.S
Smart Pills Market Revenue (US$ Mn) and Forecasts, By End Users
12.6.1.4.1. Hospitals
12.6.1.4.2. Clinics
12.6.1.4.3. Diagnostic
Centers
12.6.1.4.4. Research
Centers
12.6.1.4.5. Universities
12.6.1.4.6. Others
12.6.2. Canada
12.6.2.1. Canada
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Application
12.6.2.1.1. Diagnostic
Imaging
12.6.2.1.2. Vital
Sign Monitoring
12.6.2.1.3. Targeted
Drug Delivery
12.6.2.2. Canada
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Area
12.6.2.2.1. Esophagus
12.6.2.2.2. Stomach
12.6.2.2.3. Small
Intestine
12.6.2.2.4. Large
Intestine
12.6.2.2.5. Others
12.6.2.3. Canada
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Disease Indication
12.6.2.3.1. Acute
Gastrointestinal Bleeding
12.6.2.3.2. Crohn’s
Disease (CD)
12.6.2.3.3. Esophagitis
and Barrett’s Esophagus
12.6.2.3.4. Others
12.6.2.4. Canada
Smart Pills Market Revenue (US$ Mn) and Forecasts, By End Users
12.6.2.4.1. Hospitals
12.6.2.4.2. Clinics
12.6.2.4.3. Diagnostic
Centers
12.6.2.4.4. Research
Centers
12.6.2.4.5. Universities
12.6.2.4.6. Others
12.6.3. Mexico
12.6.3.1. Mexico
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Application
12.6.3.1.1. Diagnostic
Imaging
12.6.3.1.2. Vital
Sign Monitoring
12.6.3.1.3. Targeted
Drug Delivery
12.6.3.2. Mexico
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Area
12.6.3.2.1. Esophagus
12.6.3.2.2. Stomach
12.6.3.2.3. Small
Intestine
12.6.3.2.4. Large
Intestine
12.6.3.2.5. Others
12.6.3.3. Mexico
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Disease Indication
12.6.3.3.1. Acute
Gastrointestinal Bleeding
12.6.3.3.2. Crohn’s
Disease (CD)
12.6.3.3.3. Esophagitis
and Barrett’s Esophagus
12.6.3.3.4. Others
12.6.3.4. Mexico
Smart Pills Market Revenue (US$ Mn) and Forecasts, By End Users
12.6.3.4.1. Hospitals
12.6.3.4.2. Clinics
12.6.3.4.3. Diagnostic
Centers
12.6.3.4.4. Research
Centers
12.6.3.4.5. Universities
12.6.3.4.6. Others
12.6.4. Rest of
North America
12.6.4.1. Rest
of North America Smart Pills Market Revenue (US$ Mn) and Forecasts, By
Application
12.6.4.1.1. Diagnostic
Imaging
12.6.4.1.2. Vital
Sign Monitoring
12.6.4.1.3. Targeted
Drug Delivery
12.6.4.2. Rest
of North America Smart Pills Market Revenue (US$ Mn) and Forecasts, By Area
12.6.4.2.1. Esophagus
12.6.4.2.2. Stomach
12.6.4.2.3. Small
Intestine
12.6.4.2.4. Large
Intestine
12.6.4.2.5. Others
12.6.4.3. Rest
of North America Smart Pills Market Revenue (US$ Mn) and Forecasts, By Disease
Indication
12.6.4.3.1. Acute
Gastrointestinal Bleeding
12.6.4.3.2. Crohn’s
Disease (CD)
12.6.4.3.3. Esophagitis
and Barrett’s Esophagus
12.6.4.3.4. Others
12.6.4.4. Rest
of North America Smart Pills Market Revenue (US$ Mn) and Forecasts, By End
Users
12.6.4.4.1. Hospitals
12.6.4.4.2. Clinics
12.6.4.4.3. Diagnostic
Centers
12.6.4.4.4. Research
Centers
12.6.4.4.5. Universities
12.6.4.4.6. Others
12.7. Key
Segment for Channeling Investments
12.7.1. By
Country
12.7.2. By
Application
12.7.3. By Area
12.7.4. By
Disease Indication
12.7.5. By End
Users
13. Europe
Smart Pills Market Analysis and Forecasts, 2020 - 2028
13.1. Overview
13.1.1. Europe
Smart Pills Market Revenue (US$ Mn)
13.2. Europe
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Application
13.2.1. Diagnostic
Imaging
13.2.2. Vital
Sign Monitoring
13.2.3. Targeted
Drug Delivery
13.3. Europe
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Area
13.3.1. Esophagus
13.3.2. Stomach
13.3.3. Small
Intestine
13.3.4. Large
Intestine
13.3.5. Others
13.4. Europe
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Disease Indication
13.4.1. Acute
Gastrointestinal Bleeding
13.4.2. Crohn’s
Disease (CD)
13.4.3. Esophagitis
and Barrett’s Esophagus
13.4.4. Others
13.5. Europe
Smart Pills Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.1. Hospitals
13.5.2. Clinics
13.5.3. Diagnostic
Centers
13.5.4. Research
Centers
13.5.5. Universities
13.5.6. Others
13.6. Europe
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Country
13.6.1. France
13.6.1.1. France
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Application
13.6.1.1.1. Diagnostic
Imaging
13.6.1.1.2. Vital
Sign Monitoring
13.6.1.1.3. Targeted
Drug Delivery
13.6.1.2. France
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Area
13.6.1.2.1. Esophagus
13.6.1.2.2. Stomach
13.6.1.2.3. Small
Intestine
13.6.1.2.4. Large
Intestine
13.6.1.2.5. Others
13.6.1.3. France
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Disease Indication
13.6.1.3.1. Acute
Gastrointestinal Bleeding
13.6.1.3.2. Crohn’s
Disease (CD)
13.6.1.3.3. Esophagitis
and Barrett’s Esophagus
13.6.1.3.4. Others
13.6.1.4. France
Smart Pills Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.1.4.1. Hospitals
13.6.1.4.2. Clinics
13.6.1.4.3. Diagnostic
Centers
13.6.1.4.4. Research
Centers
13.6.1.4.5. Universities
13.6.1.4.6. Others
13.6.2. The UK
13.6.2.1. The
UK Smart Pills Market Revenue (US$ Mn) and Forecasts, By Application
13.6.2.1.1. Diagnostic
Imaging
13.6.2.1.2. Vital
Sign Monitoring
13.6.2.1.3. Targeted
Drug Delivery
13.6.2.2. The
UK Smart Pills Market Revenue (US$ Mn) and Forecasts, By Area
13.6.2.2.1. Esophagus
13.6.2.2.2. Stomach
13.6.2.2.3. Small
Intestine
13.6.2.2.4. Large
Intestine
13.6.2.2.5. Others
13.6.2.3. The
UK Smart Pills Market Revenue (US$ Mn) and Forecasts, By Disease Indication
13.6.2.3.1. Acute
Gastrointestinal Bleeding
13.6.2.3.2. Crohn’s
Disease (CD)
13.6.2.3.3. Esophagitis
and Barrett’s Esophagus
13.6.2.3.4. Others
13.6.2.4. The
UK Smart Pills Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.2.4.1. Hospitals
13.6.2.4.2. Clinics
13.6.2.4.3. Diagnostic
Centers
13.6.2.4.4. Research
Centers
13.6.2.4.5. Universities
13.6.2.4.6. Others
13.6.3. Spain
13.6.3.1. Spain
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Application
13.6.3.1.1. Diagnostic
Imaging
13.6.3.1.2. Vital
Sign Monitoring
13.6.3.1.3. Targeted
Drug Delivery
13.6.3.2. Spain
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Area
13.6.3.2.1. Esophagus
13.6.3.2.2. Stomach
13.6.3.2.3. Small
Intestine
13.6.3.2.4. Large
Intestine
13.6.3.2.5. Others
13.6.3.3. Spain
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Disease Indication
13.6.3.3.1. Acute
Gastrointestinal Bleeding
13.6.3.3.2. Crohn’s
Disease (CD)
13.6.3.3.3. Esophagitis
and Barrett’s Esophagus
13.6.3.3.4. Others
13.6.3.4. Spain
Smart Pills Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.3.4.1. Hospitals
13.6.3.4.2. Clinics
13.6.3.4.3. Diagnostic
Centers
13.6.3.4.4. Research
Centers
13.6.3.4.5. Universities
13.6.3.4.6. Others
13.6.4. Germany
13.6.4.1. Germany
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Application
13.6.4.1.1. Diagnostic
Imaging
13.6.4.1.2. Vital
Sign Monitoring
13.6.4.1.3. Targeted
Drug Delivery
13.6.4.2. Germany
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Area
13.6.4.2.1. Esophagus
13.6.4.2.2. Stomach
13.6.4.2.3. Small
Intestine
13.6.4.2.4. Large
Intestine
13.6.4.2.5. Others
13.6.4.3. Germany
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Disease Indication
13.6.4.3.1. Acute
Gastrointestinal Bleeding
13.6.4.3.2. Crohn’s
Disease (CD)
13.6.4.3.3. Esophagitis
and Barrett’s Esophagus
13.6.4.3.4. Others
13.6.4.4. Germany
Smart Pills Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.4.4.1. Hospitals
13.6.4.4.2. Clinics
13.6.4.4.3. Diagnostic
Centers
13.6.4.4.4. Research
Centers
13.6.4.4.5. Universities
13.6.4.4.6. Others
13.6.5. Italy
13.6.5.1. Italy
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Application
13.6.5.1.1. Diagnostic
Imaging
13.6.5.1.2. Vital
Sign Monitoring
13.6.5.1.3. Targeted
Drug Delivery
13.6.5.2. Italy
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Area
13.6.5.2.1. Esophagus
13.6.5.2.2. Stomach
13.6.5.2.3. Small
Intestine
13.6.5.2.4. Large
Intestine
13.6.5.2.5. Others
13.6.5.3. Italy
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Disease Indication
13.6.5.3.1. Acute
Gastrointestinal Bleeding
13.6.5.3.2. Crohn’s
Disease (CD)
13.6.5.3.3. Esophagitis
and Barrett’s Esophagus
13.6.5.3.4. Others
13.6.5.4. Italy
Smart Pills Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.5.4.1. Hospitals
13.6.5.4.2. Clinics
13.6.5.4.3. Diagnostic
Centers
13.6.5.4.4. Research
Centers
13.6.5.4.5. Universities
13.6.5.4.6. Others
13.6.6. Nordic
Countries
13.6.6.1. Nordic
Countries Smart Pills Market Revenue (US$ Mn) and Forecasts, By Application
13.6.6.1.1. Diagnostic
Imaging
13.6.6.1.2. Vital
Sign Monitoring
13.6.6.1.3. Targeted
Drug Delivery
13.6.6.2. Nordic
Countries Smart Pills Market Revenue (US$ Mn) and Forecasts, By Area
13.6.6.2.1. Esophagus
13.6.6.2.2. Stomach
13.6.6.2.3. Small
Intestine
13.6.6.2.4. Large
Intestine
13.6.6.2.5. Others
13.6.6.3. Nordic
Countries Smart Pills Market Revenue (US$ Mn) and Forecasts, By Disease
Indication
13.6.6.3.1. Acute
Gastrointestinal Bleeding
13.6.6.3.2. Crohn’s
Disease (CD)
13.6.6.3.3. Esophagitis
and Barrett’s Esophagus
13.6.6.3.4. Others
13.6.6.4. Nordic
Countries Smart Pills Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.6.4.1. Hospitals
13.6.6.4.2. Clinics
13.6.6.4.3. Diagnostic
Centers
13.6.6.4.4. Research
Centers
13.6.6.4.5. Universities
13.6.6.4.6. Others
13.6.6.5. Nordic
Countries Smart Pills Market Revenue (US$ Mn) and Forecasts, By Country
13.6.6.5.1. Denmark
13.6.6.5.2. Finland
13.6.6.5.3. Iceland
13.6.6.5.4. Sweden
13.6.6.5.5. Norway
13.6.7. Benelux
Union
13.6.7.1. Benelux
Union Smart Pills Market Revenue (US$ Mn) and Forecasts, By Application
13.6.7.1.1. Diagnostic
Imaging
13.6.7.1.2. Vital
Sign Monitoring
13.6.7.1.3. Targeted
Drug Delivery
13.6.7.2. Benelux
Union Smart Pills Market Revenue (US$ Mn) and Forecasts, By Area
13.6.7.2.1. Esophagus
13.6.7.2.2. Stomach
13.6.7.2.3. Small
Intestine
13.6.7.2.4. Large
Intestine
13.6.7.2.5. Others
13.6.7.3. Benelux
Union Smart Pills Market Revenue (US$ Mn) and Forecasts, By Disease Indication
13.6.7.3.1. Acute
Gastrointestinal Bleeding
13.6.7.3.2. Crohn’s
Disease (CD)
13.6.7.3.3. Esophagitis
and Barrett’s Esophagus
13.6.7.3.4. Others
13.6.7.4. Benelux
Union Smart Pills Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.7.4.1. Hospitals
13.6.7.4.2. Clinics
13.6.7.4.3. Diagnostic
Centers
13.6.7.4.4. Research
Centers
13.6.7.4.5. Universities
13.6.7.4.6. Others
13.6.7.5. Benelux
Union Smart Pills Market Revenue (US$ Mn) and Forecasts, By Country
13.6.7.5.1. Belgium
13.6.7.5.2. The
Netherlands
13.6.7.5.3. Luxembourg
13.6.8. Rest of
Europe
13.6.8.1. Rest
of Europe Smart Pills Market Revenue (US$ Mn) and Forecasts, By Application
13.6.8.1.1. Diagnostic
Imaging
13.6.8.1.2. Vital
Sign Monitoring
13.6.8.1.3. Targeted
Drug Delivery
13.6.8.2. Rest
of Europe Smart Pills Market Revenue (US$ Mn) and Forecasts, By Area
13.6.8.2.1. Esophagus
13.6.8.2.2. Stomach
13.6.8.2.3. Small
Intestine
13.6.8.2.4. Large
Intestine
13.6.8.2.5. Others
13.6.8.3. Rest
of Europe Smart Pills Market Revenue (US$ Mn) and Forecasts, By Disease
Indication
13.6.8.3.1. Acute
Gastrointestinal Bleeding
13.6.8.3.2. Crohn’s
Disease (CD)
13.6.8.3.3. Esophagitis
and Barrett’s Esophagus
13.6.8.3.4. Others
13.6.8.4. Rest
of Europe Smart Pills Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.8.4.1. Hospitals
13.6.8.4.2. Clinics
13.6.8.4.3. Diagnostic
Centers
13.6.8.4.4. Research
Centers
13.6.8.4.5. Universities
13.6.8.4.6. Others
13.7. Key
Segment for Channeling Investments
13.7.1. By
Country
13.7.2. By
Application
13.7.3. By Area
13.7.4. By
Disease Indication
13.7.5. By End
Users
14. Asia
Pacific Smart Pills Market Analysis and Forecasts, 2020 - 2028
14.1. Overview
14.1.1. Asia
Pacific Smart Pills Market Revenue (US$ Mn)
14.2. Asia
Pacific Smart Pills Market Revenue (US$ Mn) and Forecasts, By Application
14.2.1. Diagnostic
Imaging
14.2.2. Vital
Sign Monitoring
14.2.3. Targeted
Drug Delivery
14.3. Asia
Pacific Smart Pills Market Revenue (US$ Mn) and Forecasts, By Area
14.3.1. Esophagus
14.3.2. Stomach
14.3.3. Small
Intestine
14.3.4. Large
Intestine
14.3.5. Others
14.4. Asia
Pacific Smart Pills Market Revenue (US$ Mn) and Forecasts, By Disease
Indication
14.4.1. Acute
Gastrointestinal Bleeding
14.4.2. Crohn’s
Disease (CD)
14.4.3. Esophagitis
and Barrett’s Esophagus
14.4.4. Others
14.5. Asia
Pacific Smart Pills Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.1. Hospitals
14.5.2. Clinics
14.5.3. Diagnostic
Centers
14.5.4. Research
Centers
14.5.5. Universities
14.5.6. Others
14.6. Asia
Pacific Smart Pills Market Revenue (US$ Mn) and Forecasts, By Country
14.6.1. China
14.6.1.1. China
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Application
14.6.1.1.1. Diagnostic
Imaging
14.6.1.1.2. Vital
Sign Monitoring
14.6.1.1.3. Targeted
Drug Delivery
14.6.1.2. China
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Area
14.6.1.2.1. Esophagus
14.6.1.2.2. Stomach
14.6.1.2.3. Small
Intestine
14.6.1.2.4. Large
Intestine
14.6.1.2.5. Others
14.6.1.3. China
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Disease Indication
14.6.1.3.1. Acute
Gastrointestinal Bleeding
14.6.1.3.2. Crohn’s
Disease (CD)
14.6.1.3.3. Esophagitis
and Barrett’s Esophagus
14.6.1.3.4. Others
14.6.1.4. China
Smart Pills Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.1.4.1. Hospitals
14.6.1.4.2. Clinics
14.6.1.4.3. Diagnostic
Centers
14.6.1.4.4. Research
Centers
14.6.1.4.5. Universities
14.6.1.4.6. Others
14.6.2. Japan
14.6.2.1. Japan
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Application
14.6.2.1.1. Diagnostic
Imaging
14.6.2.1.2. Vital
Sign Monitoring
14.6.2.1.3. Targeted
Drug Delivery
14.6.2.2. Japan
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Area
14.6.2.2.1. Esophagus
14.6.2.2.2. Stomach
14.6.2.2.3. Small
Intestine
14.6.2.2.4. Large
Intestine
14.6.2.2.5. Others
14.6.2.3. Japan
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Disease Indication
14.6.2.3.1. Acute
Gastrointestinal Bleeding
14.6.2.3.2. Crohn’s
Disease (CD)
14.6.2.3.3. Esophagitis
and Barrett’s Esophagus
14.6.2.3.4. Others
14.6.2.4. Japan
Smart Pills Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.2.4.1. Hospitals
14.6.2.4.2. Clinics
14.6.2.4.3. Diagnostic
Centers
14.6.2.4.4. Research
Centers
14.6.2.4.5. Universities
14.6.2.4.6. Others
14.6.3. India
14.6.3.1. India
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Application
14.6.3.1.1. Diagnostic
Imaging
14.6.3.1.2. Vital
Sign Monitoring
14.6.3.1.3. Targeted
Drug Delivery
14.6.3.2. India
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Area
14.6.3.2.1. Esophagus
14.6.3.2.2. Stomach
14.6.3.2.3. Small
Intestine
14.6.3.2.4. Large
Intestine
14.6.3.2.5. Others
14.6.3.3. India
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Disease Indication
14.6.3.3.1. Acute
Gastrointestinal Bleeding
14.6.3.3.2. Crohn’s
Disease (CD)
14.6.3.3.3. Esophagitis
and Barrett’s Esophagus
14.6.3.3.4. Others
14.6.3.4. India
Smart Pills Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.3.4.1. Hospitals
14.6.3.4.2. Clinics
14.6.3.4.3. Diagnostic
Centers
14.6.3.4.4. Research
Centers
14.6.3.4.5. Universities
14.6.3.4.6. Others
14.6.4. New
Zealand
14.6.4.1. New
Zealand Smart Pills Market Revenue (US$ Mn) and Forecasts, By Application
14.6.4.1.1. Diagnostic
Imaging
14.6.4.1.2. Vital
Sign Monitoring
14.6.4.1.3. Targeted
Drug Delivery
14.6.4.2. New
Zealand Smart Pills Market Revenue (US$ Mn) and Forecasts, By Area
14.6.4.2.1. Esophagus
14.6.4.2.2. Stomach
14.6.4.2.3. Small
Intestine
14.6.4.2.4. Large
Intestine
14.6.4.2.5. Others
14.6.4.3. New
Zealand Smart Pills Market Revenue (US$ Mn) and Forecasts, By Disease
Indication
14.6.4.3.1. Acute
Gastrointestinal Bleeding
14.6.4.3.2. Crohn’s
Disease (CD)
14.6.4.3.3. Esophagitis
and Barrett’s Esophagus
14.6.4.3.4. Others
14.6.4.4. New
Zealand Smart Pills Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.4.4.1. Hospitals
14.6.4.4.2. Clinics
14.6.4.4.3. Diagnostic
Centers
14.6.4.4.4. Research
Centers
14.6.4.4.5. Universities
14.6.4.4.6. Others
14.6.5. Australia
14.6.5.1. Australia
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Application
14.6.5.1.1. Diagnostic
Imaging
14.6.5.1.2. Vital
Sign Monitoring
14.6.5.1.3. Targeted
Drug Delivery
14.6.5.2. Australia
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Area
14.6.5.2.1. Esophagus
14.6.5.2.2. Stomach
14.6.5.2.3. Small
Intestine
14.6.5.2.4. Large
Intestine
14.6.5.2.5. Others
14.6.5.3. Australia
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Disease Indication
14.6.5.3.1. Acute
Gastrointestinal Bleeding
14.6.5.3.2. Crohn’s
Disease (CD)
14.6.5.3.3. Esophagitis
and Barrett’s Esophagus
14.6.5.3.4. Others
14.6.5.4. Australia
Smart Pills Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.5.4.1. Hospitals
14.6.5.4.2. Clinics
14.6.5.4.3. Diagnostic
Centers
14.6.5.4.4. Research
Centers
14.6.5.4.5. Universities
14.6.5.4.6. Others
14.6.6. South
Korea
14.6.6.1. South
Korea Smart Pills Market Revenue (US$ Mn) and Forecasts, By Application
14.6.6.1.1. Diagnostic
Imaging
14.6.6.1.2. Vital
Sign Monitoring
14.6.6.1.3. Targeted
Drug Delivery
14.6.6.2. South
Korea Smart Pills Market Revenue (US$ Mn) and Forecasts, By Area
14.6.6.2.1. Esophagus
14.6.6.2.2. Stomach
14.6.6.2.3. Small
Intestine
14.6.6.2.4. Large
Intestine
14.6.6.2.5. Others
14.6.6.3. South
Korea Smart Pills Market Revenue (US$ Mn) and Forecasts, By Disease Indication
14.6.6.3.1. Acute
Gastrointestinal Bleeding
14.6.6.3.2. Crohn’s
Disease (CD)
14.6.6.3.3. Esophagitis
and Barrett’s Esophagus
14.6.6.3.4. Others
14.6.6.4. South
Korea Smart Pills Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.6.4.1. Hospitals
14.6.6.4.2. Clinics
14.6.6.4.3. Diagnostic
Centers
14.6.6.4.4. Research
Centers
14.6.6.4.5. Universities
14.6.6.4.6. Others
14.6.7. Southeast
Asia
14.6.7.1. Southeast
Asia Smart Pills Market Revenue (US$ Mn) and Forecasts, By Application
14.6.7.1.1. Diagnostic
Imaging
14.6.7.1.2. Vital
Sign Monitoring
14.6.7.1.3. Targeted
Drug Delivery
14.6.7.2. Southeast
Asia Smart Pills Market Revenue (US$ Mn) and Forecasts, By Area
14.6.7.2.1. Esophagus
14.6.7.2.2. Stomach
14.6.7.2.3. Small
Intestine
14.6.7.2.4. Large
Intestine
14.6.7.2.5. Others
14.6.7.3. Southeast
Asia Smart Pills Market Revenue (US$ Mn) and Forecasts, By Disease Indication
14.6.7.3.1. Acute
Gastrointestinal Bleeding
14.6.7.3.2. Crohn’s
Disease (CD)
14.6.7.3.3. Esophagitis
and Barrett’s Esophagus
14.6.7.3.4. Others
14.6.7.4. Southeast
Asia Smart Pills Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.7.4.1. Hospitals
14.6.7.4.2. Clinics
14.6.7.4.3. Diagnostic
Centers
14.6.7.4.4. Research
Centers
14.6.7.4.5. Universities
14.6.7.4.6. Others
14.6.7.5. Southeast
Asia Smart Pills Market Revenue (US$ Mn) and Forecasts, By Country
14.6.7.5.1. Indonesia
14.6.7.5.2. Thailand
14.6.7.5.3. Malaysia
14.6.7.5.4. Singapore
14.6.7.5.5. Rest
of Southeast Asia
14.6.8. Rest of
Asia Pacific
14.6.8.1. Rest
of Asia Pacific Smart Pills Market Revenue (US$ Mn) and Forecasts, By
Application
14.6.8.1.1. Diagnostic
Imaging
14.6.8.1.2. Vital
Sign Monitoring
14.6.8.1.3. Targeted
Drug Delivery
14.6.8.2. Rest
of Asia Pacific Smart Pills Market Revenue (US$ Mn) and Forecasts, By Area
14.6.8.2.1. Esophagus
14.6.8.2.2. Stomach
14.6.8.2.3. Small
Intestine
14.6.8.2.4. Large
Intestine
14.6.8.2.5. Others
14.6.8.3. Rest
of Asia Pacific Smart Pills Market Revenue (US$ Mn) and Forecasts, By Disease
Indication
14.6.8.3.1. Acute
Gastrointestinal Bleeding
14.6.8.3.2. Crohn’s
Disease (CD)
14.6.8.3.3. Esophagitis
and Barrett’s Esophagus
14.6.8.3.4. Others
14.6.8.4. Rest
of Asia Pacific Smart Pills Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.8.4.1. Hospitals
14.6.8.4.2. Clinics
14.6.8.4.3. Diagnostic
Centers
14.6.8.4.4. Research
Centers
14.6.8.4.5. Universities
14.6.8.4.6. Others
14.7. Key
Segment for Channeling Investments
14.7.1. By Country
14.7.2. By
Application
14.7.3. By Area
14.7.4. By
Disease Indication
14.7.5. By End
Users
15. Middle
East and Africa Smart Pills Market Analysis and Forecasts, 2020 - 2028
15.1. Overview
15.1.1. Middle
East and Africa Smart Pills Market Revenue (US$ Mn)
15.2. Middle
East and Africa Smart Pills Market Revenue (US$ Mn) and Forecasts, By
Application
15.2.1. Diagnostic
Imaging
15.2.2. Vital
Sign Monitoring
15.2.3. Targeted
Drug Delivery
15.3. Middle
East and Africa Smart Pills Market Revenue (US$ Mn) and Forecasts, By Area
15.3.1. Esophagus
15.3.2. Stomach
15.3.3. Small
Intestine
15.3.4. Large
Intestine
15.3.5. Others
15.4. Middle
East and Africa Smart Pills Market Revenue (US$ Mn) and Forecasts, By Disease
Indication
15.4.1. Acute
Gastrointestinal Bleeding
15.4.2. Crohn’s
Disease (CD)
15.4.3. Esophagitis
and Barrett’s Esophagus
15.4.4. Others
15.5. Middle
East and Africa Smart Pills Market Revenue (US$ Mn) and Forecasts, By End Users
15.5.1. Hospitals
15.5.2. Clinics
15.5.3. Diagnostic
Centers
15.5.4. Research
Centers
15.5.5. Universities
15.5.6. Others
15.6. Middle
East and Africa Smart Pills Market Revenue (US$ Mn) and Forecasts, By Country
15.6.1. Saudi
Arabia
15.6.1.1. Saudi
Arabia Smart Pills Market Revenue (US$ Mn) and Forecasts, By Application
15.6.1.1.1. Diagnostic
Imaging
15.6.1.1.2. Vital
Sign Monitoring
15.6.1.1.3. Targeted
Drug Delivery
15.6.1.2. Saudi
Arabia Smart Pills Market Revenue (US$ Mn) and Forecasts, By Area
15.6.1.2.1. Esophagus
15.6.1.2.2. Stomach
15.6.1.2.3. Small
Intestine
15.6.1.2.4. Large
Intestine
15.6.1.2.5. Others
15.6.1.3. Saudi
Arabia Smart Pills Market Revenue (US$ Mn) and Forecasts, By Disease Indication
15.6.1.3.1. Acute
Gastrointestinal Bleeding
15.6.1.3.2. Crohn’s
Disease (CD)
15.6.1.3.3. Esophagitis
and Barrett’s Esophagus
15.6.1.3.4. Others
15.6.1.4. Saudi
Arabia Smart Pills Market Revenue (US$ Mn) and Forecasts, By End Users
15.6.1.4.1. Hospitals
15.6.1.4.2. Clinics
15.6.1.4.3. Diagnostic
Centers
15.6.1.4.4. Research
Centers
15.6.1.4.5. Universities
15.6.1.4.6. Others
15.6.2. UAE
15.6.2.1. UAE
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Application
15.6.2.1.1. Diagnostic
Imaging
15.6.2.1.2. Vital
Sign Monitoring
15.6.2.1.3. Targeted
Drug Delivery
15.6.2.2. UAE
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Area
15.6.2.2.1. Esophagus
15.6.2.2.2. Stomach
15.6.2.2.3. Small
Intestine
15.6.2.2.4. Large
Intestine
15.6.2.2.5. Others
15.6.2.3. UAE
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Disease Indication
15.6.2.3.1. Acute
Gastrointestinal Bleeding
15.6.2.3.2. Crohn’s
Disease (CD)
15.6.2.3.3. Esophagitis
and Barrett’s Esophagus
15.6.2.3.4. Others
15.6.2.4. UAE
Smart Pills Market Revenue (US$ Mn) and Forecasts, By End Users
15.6.2.4.1. Hospitals
15.6.2.4.2. Clinics
15.6.2.4.3. Diagnostic
Centers
15.6.2.4.4. Research
Centers
15.6.2.4.5. Universities
15.6.2.4.6. Others
15.6.3. Egypt
15.6.3.1. Egypt
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Application
15.6.3.1.1. Diagnostic
Imaging
15.6.3.1.2. Vital
Sign Monitoring
15.6.3.1.3. Targeted
Drug Delivery
15.6.3.2. Egypt
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Area
15.6.3.2.1. Esophagus
15.6.3.2.2. Stomach
15.6.3.2.3. Small
Intestine
15.6.3.2.4. Large
Intestine
15.6.3.2.5. Others
15.6.3.3. Egypt
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Disease Indication
15.6.3.3.1. Acute
Gastrointestinal Bleeding
15.6.3.3.2. Crohn’s
Disease (CD)
15.6.3.3.3. Esophagitis
and Barrett’s Esophagus
15.6.3.3.4. Others
15.6.3.4. Egypt
Smart Pills Market Revenue (US$ Mn) and Forecasts, By End Users
15.6.3.4.1. Hospitals
15.6.3.4.2. Clinics
15.6.3.4.3. Diagnostic
Centers
15.6.3.4.4. Research
Centers
15.6.3.4.5. Universities
15.6.3.4.6. Others
15.6.4. Kuwait
15.6.4.1. Kuwait
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Application
15.6.4.1.1. Diagnostic
Imaging
15.6.4.1.2. Vital
Sign Monitoring
15.6.4.1.3. Targeted
Drug Delivery
15.6.4.2. Kuwait
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Area
15.6.4.2.1. Esophagus
15.6.4.2.2. Stomach
15.6.4.2.3. Small
Intestine
15.6.4.2.4. Large
Intestine
15.6.4.2.5. Others
15.6.4.3. Kuwait
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Disease Indication
15.6.4.3.1. Acute
Gastrointestinal Bleeding
15.6.4.3.2. Crohn’s
Disease (CD)
15.6.4.3.3. Esophagitis
and Barrett’s Esophagus
15.6.4.3.4. Others
15.6.4.4. Kuwait
Smart Pills Market Revenue (US$ Mn) and Forecasts, By End Users
15.6.4.4.1. Hospitals
15.6.4.4.2. Clinics
15.6.4.4.3. Diagnostic
Centers
15.6.4.4.4. Research
Centers
15.6.4.4.5. Universities
15.6.4.4.6. Others
15.6.5. South
Africa
15.6.5.1. South
Africa Smart Pills Market Revenue (US$ Mn) and Forecasts, By Application
15.6.5.1.1. Diagnostic
Imaging
15.6.5.1.2. Vital
Sign Monitoring
15.6.5.1.3. Targeted
Drug Delivery
15.6.5.2. South
Africa Smart Pills Market Revenue (US$ Mn) and Forecasts, By Area
15.6.5.2.1. Esophagus
15.6.5.2.2. Stomach
15.6.5.2.3. Small
Intestine
15.6.5.2.4. Large
Intestine
15.6.5.2.5. Others
15.6.5.3. South
Africa Smart Pills Market Revenue (US$ Mn) and Forecasts, By Disease Indication
15.6.5.3.1. Acute
Gastrointestinal Bleeding
15.6.5.3.2. Crohn’s
Disease (CD)
15.6.5.3.3. Esophagitis
and Barrett’s Esophagus
15.6.5.3.4. Others
15.6.5.4. South
Africa Smart Pills Market Revenue (US$ Mn) and Forecasts, By End Users
15.6.5.4.1. Hospitals
15.6.5.4.2. Clinics
15.6.5.4.3. Diagnostic
Centers
15.6.5.4.4. Research
Centers
15.6.5.4.5. Universities
15.6.5.4.6. Others
15.6.6. Rest of
Middle East & Africa
15.6.6.1. Rest
of Middle East & Africa Smart Pills Market Revenue (US$ Mn) and Forecasts,
By Application
15.6.6.1.1. Diagnostic
Imaging
15.6.6.1.2. Vital
Sign Monitoring
15.6.6.1.3. Targeted
Drug Delivery
15.6.6.2. Rest
of Middle East & Africa Smart Pills Market Revenue (US$ Mn) and Forecasts,
By Area
15.6.6.2.1. Esophagus
15.6.6.2.2. Stomach
15.6.6.2.3. Small
Intestine
15.6.6.2.4. Large
Intestine
15.6.6.2.5. Others
15.6.6.3. Rest
of Middle East & Africa Smart Pills Market Revenue (US$ Mn) and Forecasts,
By Disease Indication
15.6.6.3.1. Acute
Gastrointestinal Bleeding
15.6.6.3.2. Crohn’s
Disease (CD)
15.6.6.3.3. Esophagitis
and Barrett’s Esophagus
15.6.6.3.4. Others
15.6.6.4. Rest
of Middle East & Africa Smart Pills Market Revenue (US$ Mn) and Forecasts,
By End Users
15.6.6.4.1. Hospitals
15.6.6.4.2. Clinics
15.6.6.4.3. Diagnostic
Centers
15.6.6.4.4. Research
Centers
15.6.6.4.5. Universities
15.6.6.4.6. Others
15.7. Key
Segment for Channeling Investments
15.7.1. By
Country
15.7.2. By
Application
15.7.3. By Area
15.7.4. By
Disease Indication
15.7.5. By End
Users
16. Latin
America Smart Pills Market Analysis and Forecasts, 2020 - 2028
16.1. Overview
16.1.1. Latin
America Smart Pills Market Revenue (US$ Mn)
16.2. Latin
America Smart Pills Market Revenue (US$ Mn) and Forecasts, By Application
16.2.1. Diagnostic
Imaging
16.2.2. Vital
Sign Monitoring
16.2.3. Targeted
Drug Delivery
16.3. Latin
America Smart Pills Market Revenue (US$ Mn) and Forecasts, By Area
16.3.1. Esophagus
16.3.2. Stomach
16.3.3. Small
Intestine
16.3.4. Large
Intestine
16.3.5. Others
16.4. Latin
America Smart Pills Market Revenue (US$ Mn) and Forecasts, By Disease
Indication
16.4.1. Acute
Gastrointestinal Bleeding
16.4.2. Crohn’s
Disease (CD)
16.4.3. Esophagitis
and Barrett’s Esophagus
16.4.4. Others
16.5. Latin
America Smart Pills Market Revenue (US$ Mn) and Forecasts, By End Users
16.5.1. Hospitals
16.5.2. Clinics
16.5.3. Diagnostic
Centers
16.5.4. Research
Centers
16.5.5. Universities
16.5.6. Others
16.6. Latin
America Smart Pills Market Revenue (US$ Mn) and Forecasts, By Country
16.6.1. Brazil
16.6.1.1. Brazil
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Application
16.6.1.1.1. Diagnostic
Imaging
16.6.1.1.2. Vital
Sign Monitoring
16.6.1.1.3. Targeted
Drug Delivery
16.6.1.2. Brazil
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Area
16.6.1.2.1. Esophagus
16.6.1.2.2. Stomach
16.6.1.2.3. Small
Intestine
16.6.1.2.4. Large
Intestine
16.6.1.2.5. Others
16.6.1.3. Brazil
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Disease Indication
16.6.1.3.1. Acute
Gastrointestinal Bleeding
16.6.1.3.2. Crohn’s
Disease (CD)
16.6.1.3.3. Esophagitis
and Barrett’s Esophagus
16.6.1.3.4. Others
16.6.1.4. Brazil
Smart Pills Market Revenue (US$ Mn) and Forecasts, By End Users
16.6.1.4.1. Hospitals
16.6.1.4.2. Clinics
16.6.1.4.3. Diagnostic
Centers
16.6.1.4.4. Research
Centers
16.6.1.4.5. Universities
16.6.1.4.6. Others
16.6.2. Argentina
16.6.2.1. Argentina
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Application
16.6.2.1.1. Diagnostic
Imaging
16.6.2.1.2. Vital
Sign Monitoring
16.6.2.1.3. Targeted
Drug Delivery
16.6.2.2. Argentina
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Area
16.6.2.2.1. Esophagus
16.6.2.2.2. Stomach
16.6.2.2.3. Small
Intestine
16.6.2.2.4. Large
Intestine
16.6.2.2.5. Others
16.6.2.3. Argentina
Smart Pills Market Revenue (US$ Mn) and Forecasts, By Disease Indication
16.6.2.3.1. Acute
Gastrointestinal Bleeding
16.6.2.3.2. Crohn’s
Disease (CD)
16.6.2.3.3. Esophagitis
and Barrett’s Esophagus
16.6.2.3.4. Others
16.6.2.4. Argentina
Smart Pills Market Revenue (US$ Mn) and Forecasts, By End Users
16.6.2.4.1. Hospitals
16.6.2.4.2. Clinics
16.6.2.4.3. Diagnostic
Centers
16.6.2.4.4. Research
Centers
16.6.2.4.5. Universities
16.6.2.4.6. Others
16.6.3. Rest of
Latin America
16.6.3.1. Rest
of Latin America Smart Pills Market Revenue (US$ Mn) and Forecasts, By
Application
16.6.3.1.1. Diagnostic
Imaging
16.6.3.1.2. Vital
Sign Monitoring
16.6.3.1.3. Targeted
Drug Delivery
16.6.3.2. Rest
of Latin America Smart Pills Market Revenue (US$ Mn) and Forecasts, By Area
16.6.3.2.1. Esophagus
16.6.3.2.2. Stomach
16.6.3.2.3. Small
Intestine
16.6.3.2.4. Large
Intestine
16.6.3.2.5. Others
16.6.3.3. Rest
of Latin America Smart Pills Market Revenue (US$ Mn) and Forecasts, By Disease
Indication
16.6.3.3.1. Acute
Gastrointestinal Bleeding
16.6.3.3.2. Crohn’s
Disease (CD)
16.6.3.3.3. Esophagitis
and Barrett’s Esophagus
16.6.3.3.4. Others
16.6.3.4. Rest
of Latin America Smart Pills Market Revenue (US$ Mn) and Forecasts, By End
Users
16.6.3.4.1. Hospitals
16.6.3.4.2. Clinics
16.6.3.4.3. Diagnostic
Centers
16.6.3.4.4. Research
Centers
16.6.3.4.5. Universities
16.6.3.4.6. Others
16.7. Key
Segment for Channeling Investments
16.7.1. By
Country
16.7.2. By
Application
16.7.3. By Area
16.7.4. By
Disease Indication
16.7.5. By End
Users
17. Competitive
Benchmarking
17.1. Market
Share Analysis, 2019
17.2. Global
Presence and Growth Strategies
17.2.1. Mergers
and Acquisitions
17.2.2. Product
Launches
17.2.3. Investments
Trends
17.2.4. R&D
Initiatives
18. Player
Profiles
18.1. BDD
Pharma Ltd
18.1.1. Company
Details
18.1.2. Company
Overview
18.1.3. Product
Offerings
18.1.4. Key
Developments
18.1.5. Financial
Analysis
18.1.6. SWOT
Analysis
18.1.7. Business
Strategies
18.2. CapsoVision,
Inc.
18.2.1. Company
Details
18.2.2. Company
Overview
18.2.3. Product
Offerings
18.2.4. Key
Developments
18.2.5. Financial
Analysis
18.2.6. SWOT
Analysis
18.2.7. Business
Strategies
18.3. etectRx
18.3.1. Company
Details
18.3.2. Company
Overview
18.3.3. Product
Offerings
18.3.4. Key
Developments
18.3.5. Financial
Analysis
18.3.6. SWOT
Analysis
18.3.7. Business
Strategies
18.4. HQ, Inc.
18.4.1. Company
Details
18.4.2. Company
Overview
18.4.3. Product
Offerings
18.4.4. Key
Developments
18.4.5. Financial
Analysis
18.4.6. SWOT
Analysis
18.4.7. Business
Strategies
18.5. Medimetrics
Personalized Drug Delivery B.V.
18.5.1. Company
Details
18.5.2. Company
Overview
18.5.3. Product
Offerings
18.5.4. Key
Developments
18.5.5. Financial
Analysis
18.5.6. SWOT
Analysis
18.5.7. Business
Strategies
18.6. Medtronic
18.6.1. Company
Details
18.6.2. Company
Overview
18.6.3. Product
Offerings
18.6.4. Key
Developments
18.6.5. Financial
Analysis
18.6.6. SWOT
Analysis
18.6.7. Business
Strategies
18.7. Olympus
18.7.1. Company
Details
18.7.2. Company
Overview
18.7.3. Product
Offerings
18.7.4. Key
Developments
18.7.5. Financial
Analysis
18.7.6. SWOT
Analysis
18.7.7. Business
Strategies
18.8. Veloce
Digital Health
18.8.1. Company
Details
18.8.2. Company
Overview
18.8.3. Product
Offerings
18.8.4. Key
Developments
18.8.5. Financial
Analysis
18.8.6. SWOT
Analysis
18.8.7. Business Strategies
18.9. Other
Industry Participants
19. Key
Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and
Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.